Skip to content
Summer 2026 · 26% off every plan with SUMMER26 See pricing
Optionomics
TAYD · 10-K filed August 18, 2026

TAYD earnings analysis

What we found in TAYD's 10-K: the parts that mattered, the offsets in the same document, and what the company said about what comes next.

Our reading of the filing · Free to read, no account needed

Taylor Devices remains highly profitable and financially strong, with $52.8 million of backlog, $40.6 million of short-term investments and no drawn debt. However, fiscal 2026 revenue declined 10%, operating income fell 24%, and the business became more concentrated in aerospace/defense as structural sales weakened. The backlog supports a favorable near-term revenue outlook, but execution, margin recovery and concentration risks warrant a neutral assessment.

What stood out

The parts that mattered.

Pulled out of the filing itself, with the figures the company reported.

Specialized product platform and ongoing innovation
The company operates a specialized product platform spanning nine categories, including Seismic Dampers, Fluidicshoks®, Crane and Industrial Buffers, and Custom Actuators. Management states it continues to develop “new and advanced technology products,” including custom derivatives for aerospace and defense applications.
Backlog more than doubled
Backlog increased to $52.8 million across 139 open sales orders at May 31, 2026, from $27.1 million across 142 orders a year earlier. Aerospace/defense represented 92% of backlog versus 75% at fiscal 2025 year-end, and management expects to recognize the majority of remaining backlog revenue in fiscal 2027.
Profitable despite lower sales
The company generated $41,649,673 of fiscal 2026 revenue, $18,347,116 of gross profit and $7,342,956 of operating income, implying gross and operating margins of 44.0% and 17.6%, respectively. Diluted EPS was $2.62, compared with $2.87 in fiscal 2025.
Aerospace mix and owned capacity
Aerospace/defense revenue increased 1% to $27,522,079 and reached 66% of total revenue, while U.S. revenue represented 87% of sales. The company owns more than 54,000 square feet of facilities on Tonawanda Island plus two additional industrial buildings totaling 46,000 square feet.
Strong liquidity funds expansion
Operating cash flow was $7,023,069 in fiscal 2026, while capital expenditures were $2,136,301, primarily for manufacturing machinery, testing equipment, technology upgrades and facility improvements. The company had $40,574,152 in short-term investments and no balance outstanding on its $10,000,000 demand line of credit.
Retains cash while repurchasing shares
Capital allocation included $1,317,972 of treasury-stock purchases and $1,924,680 of proceeds from common-stock issuance, largely from option exercises. The company does not pay a cash dividend and plans to retain cash for working capital needs.
What to watch

And the other side of it.

The offsets in the same document — the things a summary that only listed the good news would have left out.

Backlog concentration in aerospace/defense
Structural sales fell 31% to $10,262,939, and structural customers declined to 25% of revenue from 32% in fiscal 2025. Structural orders were only 5% of backlog at May 31, 2026 versus 19% a year earlier, while aerospace/defense accounted for 92% of backlog, increasing dependence on one end market.
Lower revenue and margin pressure
Revenue declined 10% to $41,649,673, gross margin fell to 44% from 46%, and operating income decreased 24% to $7,342,956. Long-term-project revenue was 25% lower year over year, while research and development costs increased 75% to $775,995, creating pressure for future project execution and margin recovery.
Newly expanded construction litigation
The company was named in third-party claims related to the 432 Park Avenue litigation, including claims associated with a June 15, 2026 amended fraud complaint. Discovery in the Fraud Action remains ongoing and is expected to conclude around February 26, 2027; the company states it cannot determine the likelihood of an unfavorable outcome or quantify a potential loss.
The numbers

What they reported.

What the company itself reported, taken out of the document.

What survived to operating profit
Of every $100 of revenue Cost of sales $56 Operating expenses $26 Left as operating profit $18
Percentages of revenue, taken from the filing. Drawn this way because it holds whatever scale the company reports in.
Earnings per share
$2.62
Gross margin
44%
Operating margin
17.6%
Segment
Single operating segment: Taylor Devices manufactures shock absorption, rate control and energy storage products across nine product categories.
Segment
Customer mix: Aerospace/Defense $27,522,079 (66% of revenue); Structural $10,262,939 (25%); Industrial $3,864,655 (9%).
Segment
Geographic mix: United States 87% of revenue; Asia 8%; other countries 5%.
Guidance

What they said about what is next.

No numeric annual or quarterly revenue/EPS guidance is provided. Management expects to recognize the majority of remaining backlog during fiscal 2027, with the balance during fiscal 2028; a $19.0 million non-project order is scheduled for delivery of $1.7 million in fiscal 2027, $5.0 million in fiscal 2028, $10.0 million in fiscal 2029 and $2.3 million in fiscal 2030.

How we read the filing overall

The filing reads about the same as the one before it.

One reading of one document. It is not advice, and it is not a forecast.
Earlier filings

What came before.

10-Q · March 31, 2026
Taylor Devices reported Q3 sales of $11,173,201 (a 6% increase vs. the prior-year quarter) and diluted EPS of $0.79 (up from $0.64). Gross margin compressed to 40% (down 3 percentage points year-over-year) while…
10-K · August 15, 2025
Taylor Devices, Inc. reported notable revenue growth in its 2025 10-K filing, achieving a record high in quarterly sales of $15,561,154 and full-year revenues of $46,293,000, an increase of 4% from the previous year.…
10-Q · March 28, 2025
Taylor Devices reported quarterly sales of $10,564,834 and diluted EPS of $0.64 for the three months ended February 28, 2025. Revenue and gross profit were down versus the prior-year quarter (sales fell $1,689,259 or…
10-Q · January 3, 2025
Taylor Devices reported Q2 sales of $8,548,881 (down $1,791,000 or 17% vs. Q2 prior year) and diluted EPS of $0.34 (down from $0.56). Gross margin contracted to 45% (vs. 47% prior year) and operating income fell to…

This is our reading of a public filing, not the filing. Read the original on SEC.gov · Educational only. Nothing here is investment advice.

Read the next one first.

We read every filing TAYD makes the day it lands, and put it next to what the options market did about it. Members get both, and an alert when a filing arrives.

Cancel anytime · Month to month · Switch tiers whenever